Vivos Therapeutics, Inc. Depreciation
Vivos Therapeutics, Inc. (VVOS) reported Depreciation of $300.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-14
- Vivos Therapeutics, Inc. depreciation for the quarter ending 2026-06-30 was $300.00K, a 0.00% change year-over-year.
- Vivos Therapeutics, Inc. depreciation for the quarter ending 2026-03-31 was $300.00K, a 50.00% increase year-over-year.
- Vivos Therapeutics, Inc. depreciation for the quarter ending 2025-12-31 was -$200.00K, a 300.00% decline year-over-year.
- Vivos Therapeutics, Inc. depreciation for the quarter ending 2025-09-30 was $400.00K, a 300.00% increase year-over-year.
- Vivos Therapeutics, Inc. depreciation for fiscal 2025 was $700.00K, a 40.00% increase from fiscal 2024.
- Vivos Therapeutics, Inc. depreciation for fiscal 2024 was $500.00K, a 16.67% decline from fiscal 2023.
- Vivos Therapeutics, Inc. depreciation for fiscal 2023 was $600.00K, a 0.00% change from fiscal 2022.
- Vivos Therapeutics, Inc. depreciation for fiscal 2022 was $600.00K, a 50.00% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 9 month as first filed | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $300.00K 10-Q · filed 2026-08-14 | $600.00K 10-Q · filed 2026-08-14 | $400.00K derived: sum of 3 quarters · filed 2026-08-14 | $800.00K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | $300.00K 10-Q · filed 2026-05-20 | $100.00K derived: sum of 2 quarters · filed 2026-05-20 | $500.00K derived: sum of 3 quarters · filed 2026-05-20 | $800.00K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | -$200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $200.00K derived: sum of 2 quarters · filed 2026-04-15 | $500.00K derived: sum of 3 quarters · filed 2026-08-14 | $700.00K 10-K · filed 2026-04-15 | ||||
| 2025-09-30 | $400.00K 10-Q · filed 2025-11-19 | $700.00K derived: sum of 2 quarters · filed 2026-08-14 | $900.00K 10-Q · filed 2025-11-19 | $1.00M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | $300.00K 10-Q · filed 2026-08-14 | $400.00K 10-Q · filed 2026-08-14 | $600.00K derived: sum of 3 quarters · filed 2026-08-14 | $700.00K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | $200.00K 10-Q · filed 2026-05-20 | $300.00K derived: sum of 2 quarters · filed 2026-05-20 | $400.00K derived: sum of 3 quarters · filed 2026-05-20 | $500.00K derived: sum of 4 quarters · filed 2026-05-20 | ||||
| 2024-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $200.00K derived: sum of 2 quarters · filed 2026-04-15 | $300.00K derived: sum of 3 quarters · filed 2026-04-15 | $500.00K 10-K · filed 2026-04-15 | $600.00K 10-K · filed 2025-03-31 | |||
| 2024-09-30 | $100.00K 10-Q · filed 2025-11-19 | $200.00K derived: sum of 2 quarters · filed 2025-11-19 | $400.00K 10-Q · filed 2025-11-19 | $500.00K derived: sum of 4 quarters · filed 2025-11-19 | ||||
| 2024-06-30 | $100.00K 10-Q · filed 2025-08-19 | $300.00K 10-Q · filed 2025-08-19 | $400.00K derived: sum of 3 quarters · filed 2025-08-19 | $500.00K derived: sum of 4 quarters · filed 2025-08-19 | ||||
| 2024-03-31 | $100.00K 10-Q · filed 2025-05-15 | $300.00K derived: sum of 2 quarters · filed 2025-05-15 | $400.00K derived: sum of 3 quarters · filed 2025-05-15 | $500.00K derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $300.00K derived: sum of 2 quarters · filed 2025-03-31 | $400.00K derived: sum of 3 quarters · filed 2025-03-31 | $600.00K 10-K · filed 2025-03-31 | $700.00K 10-K · filed 2024-03-28 | |||
| 2023-09-30 | $100.00K 10-Q · filed 2024-11-14 | $200.00K 10-Q · filed 2023-11-14 | $200.00K derived: sum of 2 quarters · filed 2024-11-14 | $400.00K 10-Q · filed 2024-11-14 | $500.00K 10-Q · filed 2023-11-14 | $700.00K derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | $100.00K 10-Q · filed 2024-08-14 | $300.00K 10-Q · filed 2024-08-14 | $600.00K derived: sum of 3 quarters · filed 2024-08-14 | $800.00K derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $200.00K 10-Q · filed 2024-05-14 | $500.00K derived: sum of 2 quarters · filed 2024-07-30 | $700.00K derived: sum of 3 quarters · filed 2024-07-30 | $900.00K derived: sum of 4 quarters · filed 2024-07-30 | ||||
| 2022-12-31 | $300.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-07-30 | $500.00K derived: sum of 2 quarters · filed 2024-07-30 | $700.00K derived: sum of 3 quarters · filed 2024-07-30 | $600.00K 10-K/A · filed 2024-07-30 | ||||
| 2022-09-30 | $200.00K 10-Q · filed 2023-11-14 | $400.00K derived: sum of 2 quarters · filed 2023-11-14 | $300.00K 10-Q · filed 2023-11-14 | $500.00K 10-Q · filed 2022-12-20 | $700.00K derived: sum of 4 quarters · filed 2023-11-14 | |||
| 2022-06-30 | $200.00K 10-Q · filed 2022-12-20 | $400.00K derived: sum of 2 quarters · filed 2022-12-20 | $500.00K derived: sum of 3 quarters · filed 2023-03-30 | $600.00K derived: sum of 4 quarters · filed 2023-03-30 | ||||
| 2022-03-31 | $200.00K 10-Q/A · filed 2022-11-25 | $300.00K derived: sum of 2 quarters · filed 2023-03-30 | $400.00K derived: sum of 3 quarters · filed 2023-03-30 | $480.60K derived: sum of 4 quarters · filed 2023-03-30 | ||||
| 2021-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $200.00K derived: sum of 2 quarters · filed 2023-03-30 | $280.60K derived: sum of 3 quarters · filed 2023-03-30 | $400.00K 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | $100.00K 10-Q · filed 2022-12-20 | $130.58K 10-Q · filed 2021-11-15 | $180.60K derived: sum of 2 quarters · filed 2022-12-20 | $300.00K 10-Q · filed 2022-12-20 | $283.91K 10-Q · filed 2021-11-15 | $266.32K derived: sum of 4 quarters · filed 2022-12-20 | ||
| 2021-06-30 | $80.60K 10-Q · filed 2021-08-12 | $100.00K 10-Q · filed 2022-12-20 | $153.33K 10-Q · filed 2021-08-12 | $166.32K derived: sum of 3 quarters · filed 2022-11-25 | $328.50K derived: sum of 4 quarters · filed 2022-11-25 | |||
| 2021-03-31 | $100.00K 10-Q/A · filed 2022-11-25 | $72.73K 10-Q · filed 2021-05-17 | $85.73K derived: sum of 2 quarters · filed 2022-11-25 | $247.91K derived: sum of 3 quarters · filed 2022-11-25 | $323.79K derived: sum of 4 quarters · filed 2022-11-25 | |||
| 2020-12-31 | -$14.27K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $147.91K derived: sum of 2 quarters · filed 2022-03-31 | $223.79K derived: sum of 3 quarters · filed 2022-03-31 | $300.00K 10-K · filed 2022-03-31 | $298.84K 10-K · filed 2021-03-25 | |||
| 2020-09-30 | $162.18K 10-Q · filed 2021-11-15 | $238.06K derived: sum of 2 quarters · filed 2021-11-15 | $314.27K 10-Q · filed 2021-11-15 | |||||
| 2020-06-30 | $75.88K 10-Q · filed 2021-08-12 | $152.09K 10-Q · filed 2021-08-12 | ||||||
| 2020-03-31 | $76.21K 10-Q · filed 2021-05-17 | |||||||
| 2019-12-31 | $326.85K 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |